NEUCA S.A. (WSE:NEU)
750.00
+10.00 (1.35%)
Oct 24, 2025, 4:41 PM CET
NEUCA Revenue
NEUCA had revenue of 3.27B PLN in the quarter ending June 30, 2025, with 7.38% growth. This brings the company's revenue in the last twelve months to 13.04B, up 7.55% year-over-year. In the year 2024, NEUCA had annual revenue of 12.61B with 6.76% growth.
Revenue (ttm)
13.04B
Revenue Growth
+7.55%
P/S Ratio
0.26
Revenue / Employee
2.93M
Employees
4,445
Market Cap
3.36B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 12.61B | 799.12M | 6.76% |
| Dec 31, 2023 | 11.81B | 580.45M | 5.17% |
| Dec 31, 2022 | 11.23B | 1.37B | 13.87% |
| Dec 31, 2021 | 9.86B | 619.37M | 6.70% |
| Dec 31, 2020 | 9.24B | 972.52M | 11.76% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Diagnostyka | 2.17B |
| Centrum Medyczne ENEL-MED | 789.78M |
| Synektik Spólka Akcyjna | 623.20M |
| Mercator Medical | 579.83M |
| Voxel | 560.38M |
| Selvita | 373.90M |
| BIOTON | 265.14M |
| Celon Pharma | 206.22M |